WO1998005964A1 - A method for preserving and enhancing visualization of immunodiffusion reactions - Google Patents

A method for preserving and enhancing visualization of immunodiffusion reactions Download PDF

Info

Publication number
WO1998005964A1
WO1998005964A1 PCT/US1996/012690 US9612690W WO9805964A1 WO 1998005964 A1 WO1998005964 A1 WO 1998005964A1 US 9612690 W US9612690 W US 9612690W WO 9805964 A1 WO9805964 A1 WO 9805964A1
Authority
WO
WIPO (PCT)
Prior art keywords
semi
gel
reaction
immunodiffusion
solid gel
Prior art date
Application number
PCT/US1996/012690
Other languages
French (fr)
Inventor
Curtis Sharon
Lisa Nakakihara
Original Assignee
Qed Bioscience, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qed Bioscience, Inc. filed Critical Qed Bioscience, Inc.
Priority to PCT/US1996/012690 priority Critical patent/WO1998005964A1/en
Priority to AU68425/96A priority patent/AU6842596A/en
Publication of WO1998005964A1 publication Critical patent/WO1998005964A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique

Definitions

  • This invention relates to immunodiffusion technology which yields a permanent visualization of the immunodiffusion reaction.
  • Immunodiffusion refers to an immunological reaction in which one of the reactants diffuses into a supporting gel containing another reactant.
  • the objective is to visualize and immobilize an jLn vitro reaction between, e.g., a precipitating antibody and a soluble antigen.
  • Immunodiffusion is carried out either as single radial immunodiffusion (SRI) or as double radial diffusion (DRI) .
  • SRI single radial immunodiffusion
  • DRI double radial diffusion
  • SRI only one reactant, usually the antibody, is included in the gel, i.e., the antigen, is contained in a well, cut into gel from which it diffuses radially.
  • the antibody may be contained in the well from which it diffuses into the gel containing the antigen.
  • a precipitate ring is formed around the well by contact of the diffusing reactant with the reactant contained in the gel.
  • DRI each reactant diffuses from a different well into a neutral gel.
  • immunoelectrophoresis or electroimmunoprecipitation refer to methods in which immunoprecipitation is obtained after electrophoretic separation of proteins in an electric field.
  • electrophoresis of an antigen is performed in a gel containing the corresponding antibody, a precipitate is obtained with a rocketlike appearance, the height of which is proportional to the amount of antigen in the gel.
  • SRI The antecedent of SRI is the observation of Petrie in 1932 that a ring of precipitate formed around a colony of an exotoxin-producing bacterium growing an agar which contained the specific antitoxin.
  • Ouchterlony and Elek independently adapted this observation to produce a double immunodiffusion technique.
  • Wells were produced in an agar plate, using a template or cutter. Individual wells received either antigen or antiserum. As the two reactants diffused into the gel, a line of precipitate formed within the zone of overlap. This technique, although a useful qualitative technique for demonstrating and comparing antigens and antibodies, is inadequate for quantitative determinations.
  • To asi and Zigelbaum modified the Feinberg technique by eliminating the need to achieve an endpoint.
  • the diameters of the precipitate rings were measured by placing a transparent ruler beneath the plate and plotting the diameters against antigen concentrations.
  • the area circumscribed by the ring is proportional to the concentration of the antigen in the well. Since area is proportional to the square of the radius (and, hence, to the square of the diameter, D) , then the square of the diameter (D 2 ) of the ring is proportional to the concentration of antigen. Such being the case, plotting D 2 against concentration on arithmetic graph paper will produce a straight line. Alternatively, to avoid the requirement of calculating D 2 , se ilog graph paper may be used, plotting D itself on the linear sale against antigen concentration on the log scale.
  • Immunodiffusion reactions are generally carried out in an agarose gel.
  • the molten gel is cooled to -50 °C to avoid heat denaturation of the antiserum, which is warmed to a similar temperature and added to the molten gel in desired concentration, the two are mixed gently, but thoroughly, and poured into a dish, or onto a glass plate (e.g., a microscope slide) , supported on a perfectly horizontal surface to ensure uniform gel thickness.
  • a glass plate e.g., a microscope slide
  • wells are cut using a sharp cutting instrument designed for the purpose.
  • a plastic mask with a pattern of holes can be floated on the molten gel, which is then allowed to set to form a fir seal between mask and gel. In this case, wells need not be cut, the antigen solution being applied to the exposed areas of gel .
  • the plates are incubated in a humid atmosphere, preferably until ring formation is complete.
  • Measurement of the ring diameters may be done with a transparent ruler or, more conveniently, with the wedge-shaped scale introduced by McSwiney.
  • Mechanical aids for reading ring diameters are also available commercially. These include a modified jeweller's eye-piece with an in-built graduated scale and electronic plate-readers.
  • a focal aspect of this invention is the discovery of technology effective to provide a dried semi-solid gel including a visualized immunodiffusion reaction in which the precipitate rings are preserved.
  • the dried gel is adherent to a supporting substrate, such as a glass or synthetic resin sheet.
  • Another aspect of the invention is the discovery that staining of immunoassay precipitation rings may be eliminated by incorporation of a dye into the sample solution.
  • FIGURES Figure 1 is a general depiction of prior art single and double diffusion assays.
  • Figure 2 illustrates the production of a solidified gel layer on a support with holes provided therein.
  • Figure 3 illustrates the production of a diluted sample including a buffer and a dye.
  • Figure 4 represents the solidified gel having holes therein and further having the diluted sample solution pipetted into the holes followed by overnight incubation.
  • Figure 5 illustrates the positioning of the web or blotting paper on the surface of the gel including the visualized reaction, the heating of the complex so formed, and the removal of the web or blotting paper leaving the preserved assay.
  • a support surface is provided with a layer of any gel having an aqueous continuous phase which allows free diffusion of molecules preferably in three dimensions.
  • Agarose gel is preferred.
  • Polyacrylamide gels are also useful in the practice of the invention.
  • Any solid support surface, including glass, to which the gel binds or adheres may be utilized.
  • Sheets useful as support surfaces preferably semi- rigid or flexible, may be of any desired thickness, preferably to mm. , and may be formed from any normally solid synthetic resin.
  • Useful synthetic resins include polyolefins, e.g., polyethylene and polypropylene, polyvinyl resins. e.g., polymethylmethacrylate and polystyrene, and polycarbonates.
  • Synthetic resin support sheets coated with a thin layer of the gel used in the invention are particularly preferred.
  • An example of such a support sheet is the Gel Bond ® product available from FMC Bioproducts, Inc., 5 Maple Street, Rockland, Maine.
  • Gel Bond ® is a flexible synthetic resin sheet coated with a thin layer of dried agarose.
  • the gel may contain an antibody corresponding to an antigen present in a sample to be assayed.
  • Antigen containing sample preferably containing a dye, e.g., Coomassie blue, which does not interfere with the immunoprecipitation reaction, and diluted with aqueous buffer to provide a pH of from about 6.8 to 7.4 is placed in a hole in the gel.
  • a preferred buffer is IM Glycine 20 mM Tris 0.1% sodium azide. Other buffers which may be used will be known to the art.
  • the antigen diffuses from the hole or holes into the antibody containing gel where it undergoes an immunoprecipitation reaction to provide Coomassie blue dyed precipitate rings around the hole in the gel from which it diffuses.
  • a sheet of absorbent material e.g., blotting paper
  • This procedure provides a complex comprising the gel and the sheet of absorbent material which facilitates capillary action and which facilitates even drying of the gel and tends to avoid deforming the precipitate rings.
  • the complex is placed in or on a warming device to dry the gel. As the temperature of the complex is elevated, water evaporates from the surface of the absorbent material which concurrently absorbs water from the gel .
  • the dried gel preferably on a support surface, is a permanent record of the precipitate rings formed in the immunodiffusion reaction.
  • a Gel Bond ® Sheet 1 comprising a flexible synthetic resin substrate having a surface area 2 coated with a thin layer of dried agarose which provides a hydrophilic surface to which liquid or molten agarose binds is selected to support an agarose gel layer.
  • the Gel Bond ® Sheet 1 is warmed by lamp 3 to a temperature of 40 to 55°C.
  • Liquid agarose 4 containing an antibody is poured from container 5 onto the adhesive area 2 of the Gel Bond ® Sheet 1 in an amount sufficient to provide an antibody containing agarose gel layer 6 approximately 3 mm in thickness.
  • Reagent holes 7 are provided in the gel layer 6.
  • Figure 3 illustrates a container 8, such as a test tube, containing a sample 9 which may include an antigen to be assayed.
  • a second container 10 containing an aqueous solution 11 buffered to a pH of about 7.4 of a dye, e.g., Coomassie blue, is separately provided.
  • a dye e.g., Coomassie blue
  • Appropriate buffers include Tris, Hepes, PBS, etc.
  • the sample 9 and buffered dye solution 11 are combined in container 12 to provide a diluted and buffered sample 13 containing the antigen and the dye.
  • Figure 4 depicts the solidified antibody containing agarose gel layer 6 supported by the Gel Bond ® Sheet 1 and provided with reagent holes 7.
  • Diluted and buffered antigen sample 13 containing the dye is transferred by pipette 14 from container 15 to some, but not all, of the reagent holes 7 in the solidified antibody containing gel layer 6.
  • the gel is incubated at a temperature of about 20 to 24 °C for about 24 to 48 hours to permit diffusion of the diluted antigen containing sample into the antibody containing gel layer 6.
  • the assay is visualized by precipitate rings 16 which form where the antigen of the diluted sample reacts with the antibody in the solidified gel. The rings are visualized by the dye.
  • Figure 5 shows the application of blotting paper 17 to a moist surface of the gel 6 which includes the visualized precipitate rings 16.
  • the gel is heated and dried on a warmer 18.
  • the dried gel including the visualized precipitate rings is removed from the warmer and may be retained as a permanent record.

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for preserving a visualization of an immunodiffusion reaction comprising (i) providing an immunodiffusion reaction in a hydrated semi-solid gel (6), (ii) placing a wetted water absorbent web, e.g. wetted blotting paper (17), on the surface of the reacted immunodiffusion gel (6), and (iii) drying the gel at an elevated temperature such that the gel dries evenly, is described.

Description

A METHOD FOR PRESERVING AND ENHANCING VISUALIZATION OF IMMUNODIFFUSION REACTIONS
FIELD OF THE INVENTION This invention relates to immunodiffusion technology which yields a permanent visualization of the immunodiffusion reaction.
BACKGROUND OF THE INVENTION Immunodiffusion refers to an immunological reaction in which one of the reactants diffuses into a supporting gel containing another reactant. The objective is to visualize and immobilize an jLn vitro reaction between, e.g., a precipitating antibody and a soluble antigen.
Immunodiffusion is carried out either as single radial immunodiffusion (SRI) or as double radial diffusion (DRI) . In SRI, only one reactant, usually the antibody, is included in the gel, i.e., the antigen, is contained in a well, cut into gel from which it diffuses radially. Alternatively, the antibody may be contained in the well from which it diffuses into the gel containing the antigen. A precipitate ring is formed around the well by contact of the diffusing reactant with the reactant contained in the gel. In DRI, each reactant diffuses from a different well into a neutral gel. The assay results of prior art SRI and DRI techniques are generally indicated by Figure l (prior art) .
The terms immunoelectrophoresis or electroimmunoprecipitation refer to methods in which immunoprecipitation is obtained after electrophoretic separation of proteins in an electric field. When electrophoresis of an antigen is performed in a gel containing the corresponding antibody, a precipitate is obtained with a rocketlike appearance, the height of which is proportional to the amount of antigen in the gel.
The antecedent of SRI is the observation of Petrie in 1932 that a ring of precipitate formed around a colony of an exotoxin-producing bacterium growing an agar which contained the specific antitoxin. In 1949, Ouchterlony and Elek independently adapted this observation to produce a double immunodiffusion technique. Wells were produced in an agar plate, using a template or cutter. Individual wells received either antigen or antiserum. As the two reactants diffused into the gel, a line of precipitate formed within the zone of overlap. This technique, although a useful qualitative technique for demonstrating and comparing antigens and antibodies, is inadequate for quantitative determinations.
Simultaneously, Oudin was transferring Petrie's observations to a tube, showing that rings of precipitate would form in a gel containing antiserum when it was overlaid with a solution of the corresponding antigen. This was single diffusion, as for the purpose of the method only the antigen diffusion was of consequence. It was a dynamic system, the precipitate rings migrating linearly down the gel with time; thus, single linear immunodiffusion. As the rate of the ring migration was determined by antigen concentration, it could be used for quantification of antigens against known standards.
In 1957, Feinberg combined Oudin's tube single diffusion with the Ouchterlony plate to produce a single radial immunodiffusion system. As in Oudin's technique, serum was incorporated in a molten gel, but as with Ouchterlony, the gel was poured into a plate and allowed to set. With a specially designed gel cutter, uniform wells were cut in the antiserum-gel and filled with antigen solution, using standard concentrations of the antigen for comparison with test antigens. Diffusion of antigen and formation of the precipitate rings were allowed to go to completion. Assay was based on a limiting dilution endpoint, i.e., the lowest concentration of antigen showing a ring of precipitate.
In 1963, To asi and Zigelbaum modified the Feinberg technique by eliminating the need to achieve an endpoint. The diameters of the precipitate rings were measured by placing a transparent ruler beneath the plate and plotting the diameters against antigen concentrations.
In 1965, Mancini and coworkers suggested that merely recording ring diameters could give erroneous results. They advocated projection of the rings onto strong paper, outlining the projected rings with pencil, cutting the paper discs outlined and weighing them. This so-called "Mancini technique" proved to be cumbersome, as subsequently acknowledged by Heremans. Because of this, in practice it has largely been abandoned, whereas the Tomasi and Zigelbaum modification of the Feinberg technique has generally been adopted as the method of choice and now forms the basis of commercially supplied immunodiffusion plates for the immunoassay of proteins in plasma and body fluids.
In SRI, when antigen diffuses radially into a gel containing antiserum, immune complexes are formed and a precipitate begins to deposit as a ring at the interface between the two reactants. The higher the concentration of antigen in the well, the more rapidly precipitate takes place, i.e., rings appear sequentially in direct relationship to antigen concentration. Ongoing diffusion of antigen from the well builds up the precipitate at the outer edge of the ring, where the antigen encounters additional antibody. Therefore, the system is initially in a dynamic state in which the rings increase in size with time. A static stage is reached when all the antigen has diffused into the gel and precipitate is complete. At this stage, the rings are most distinct and remain constant in size, so readings can conveniently be taken at any time thereafter. At the static stage, the area circumscribed by the ring is proportional to the concentration of the antigen in the well. Since area is proportional to the square of the radius (and, hence, to the square of the diameter, D) , then the square of the diameter (D2) of the ring is proportional to the concentration of antigen. Such being the case, plotting D2 against concentration on arithmetic graph paper will produce a straight line. Alternatively, to avoid the requirement of calculating D2, se ilog graph paper may be used, plotting D itself on the linear sale against antigen concentration on the log scale.
Immunodiffusion reactions are generally carried out in an agarose gel. For example, in SRI techniques, the molten gel is cooled to -50 °C to avoid heat denaturation of the antiserum, which is warmed to a similar temperature and added to the molten gel in desired concentration, the two are mixed gently, but thoroughly, and poured into a dish, or onto a glass plate (e.g., a microscope slide) , supported on a perfectly horizontal surface to ensure uniform gel thickness. When the gel has set, wells are cut using a sharp cutting instrument designed for the purpose. Alteratively, a plastic mask with a pattern of holes can be floated on the molten gel, which is then allowed to set to form a fir seal between mask and gel. In this case, wells need not be cut, the antigen solution being applied to the exposed areas of gel .
The plates are incubated in a humid atmosphere, preferably until ring formation is complete.
Measurement of the ring diameters may be done with a transparent ruler or, more conveniently, with the wedge-shaped scale introduced by McSwiney. Mechanical aids for reading ring diameters are also available commercially. These include a modified jeweller's eye-piece with an in-built graduated scale and electronic plate-readers.
These prior art techniques require that the results of the assay be determined while the gel is still semi-solid and visualized by incident light. Efficiency is compromised by a frequent need to stain the precipitate rings. Because gels cannot be permanently stored in a hydrated or semi-solid state, the real data reflecting the immunodiffusion reactions is lost when the gel dehydrates or is destroyed. Accordingly, a need exists for technology which eliminates staining of the precipitate rings and allows the results of immunodiffusion reactions to be stored permanently. SUMMARY OF THE INVENTION
A focal aspect of this invention is the discovery of technology effective to provide a dried semi-solid gel including a visualized immunodiffusion reaction in which the precipitate rings are preserved. Preferably, the dried gel is adherent to a supporting substrate, such as a glass or synthetic resin sheet.
Another aspect of the invention is the discovery that staining of immunoassay precipitation rings may be eliminated by incorporation of a dye into the sample solution.
DESCRIPTION OF THE FIGURES Figure 1 is a general depiction of prior art single and double diffusion assays.
Figure 2 illustrates the production of a solidified gel layer on a support with holes provided therein.
Figure 3 illustrates the production of a diluted sample including a buffer and a dye.
Figure 4 represents the solidified gel having holes therein and further having the diluted sample solution pipetted into the holes followed by overnight incubation. Figure 5 illustrates the positioning of the web or blotting paper on the surface of the gel including the visualized reaction, the heating of the complex so formed, and the removal of the web or blotting paper leaving the preserved assay. DETAILED DESCRIPTION OF THE INVENTION
Pursuant to this invention, a support surface is provided with a layer of any gel having an aqueous continuous phase which allows free diffusion of molecules preferably in three dimensions. Agarose gel is preferred. Polyacrylamide gels are also useful in the practice of the invention.
Any solid support surface, including glass, to which the gel binds or adheres may be utilized. Sheets useful as support surfaces, preferably semi- rigid or flexible, may be of any desired thickness, preferably to mm. , and may be formed from any normally solid synthetic resin. Useful synthetic resins include polyolefins, e.g., polyethylene and polypropylene, polyvinyl resins. e.g., polymethylmethacrylate and polystyrene, and polycarbonates.
Synthetic resin support sheets coated with a thin layer of the gel used in the invention are particularly preferred. An example of such a support sheet is the Gel Bond® product available from FMC Bioproducts, Inc., 5 Maple Street, Rockland, Maine. Gel Bond® is a flexible synthetic resin sheet coated with a thin layer of dried agarose.
The gel may contain an antibody corresponding to an antigen present in a sample to be assayed.
Antigen containing sample, preferably containing a dye, e.g., Coomassie blue, which does not interfere with the immunoprecipitation reaction, and diluted with aqueous buffer to provide a pH of from about 6.8 to 7.4 is placed in a hole in the gel. A preferred buffer is IM Glycine 20 mM Tris 0.1% sodium azide. Other buffers which may be used will be known to the art. The antigen diffuses from the hole or holes into the antibody containing gel where it undergoes an immunoprecipitation reaction to provide Coomassie blue dyed precipitate rings around the hole in the gel from which it diffuses.
A sheet of absorbent material, e.g., blotting paper, is placed in contact with the gel surface, and wetted, preferably with distilled water. This procedure provides a complex comprising the gel and the sheet of absorbent material which facilitates capillary action and which facilitates even drying of the gel and tends to avoid deforming the precipitate rings. The complex is placed in or on a warming device to dry the gel. As the temperature of the complex is elevated, water evaporates from the surface of the absorbent material which concurrently absorbs water from the gel . The dried gel, preferably on a support surface, is a permanent record of the precipitate rings formed in the immunodiffusion reaction.
The invention is now more fully explained by reference to Figures 1 to 5.
Referring to Figure 2, a Gel Bond® Sheet 1 comprising a flexible synthetic resin substrate having a surface area 2 coated with a thin layer of dried agarose which provides a hydrophilic surface to which liquid or molten agarose binds is selected to support an agarose gel layer. The Gel Bond® Sheet 1 is warmed by lamp 3 to a temperature of 40 to 55°C. Liquid agarose 4 containing an antibody is poured from container 5 onto the adhesive area 2 of the Gel Bond® Sheet 1 in an amount sufficient to provide an antibody containing agarose gel layer 6 approximately 3 mm in thickness. Reagent holes 7 are provided in the gel layer 6.
Figure 3 illustrates a container 8, such as a test tube, containing a sample 9 which may include an antigen to be assayed. A second container 10 containing an aqueous solution 11 buffered to a pH of about 7.4 of a dye, e.g., Coomassie blue, is separately provided. Appropriate buffers include Tris, Hepes, PBS, etc. The sample 9 and buffered dye solution 11 are combined in container 12 to provide a diluted and buffered sample 13 containing the antigen and the dye.
Figure 4 depicts the solidified antibody containing agarose gel layer 6 supported by the Gel Bond® Sheet 1 and provided with reagent holes 7. Diluted and buffered antigen sample 13 containing the dye is transferred by pipette 14 from container 15 to some, but not all, of the reagent holes 7 in the solidified antibody containing gel layer 6. The gel is incubated at a temperature of about 20 to 24 °C for about 24 to 48 hours to permit diffusion of the diluted antigen containing sample into the antibody containing gel layer 6. The assay is visualized by precipitate rings 16 which form where the antigen of the diluted sample reacts with the antibody in the solidified gel. The rings are visualized by the dye.
Figure 5 shows the application of blotting paper 17 to a moist surface of the gel 6 which includes the visualized precipitate rings 16. The gel is heated and dried on a warmer 18. The dried gel including the visualized precipitate rings is removed from the warmer and may be retained as a permanent record.
Prior art immunodiffusion assays do not yield convenient and permanent records of the original data. Pursuant to this invention, the visualized assay per se is stored and constitutes the truest raw data available. This is particularly advantageous in those fields that require comparison of raw data from a plurality of assays.

Claims

1. A method for preserving a visualization of an immunodiffusion reaction which comprises:
(i) providing a hydrated semi-solid gel in which an immunodiffusion reaction is visualized,
(ii) placing a wetted water absorbent web on the surface of said semi-solid gel in which said immunodiffusion reaction is visualized to provide a complex comprising said semi-solid gel and said absorbent web; and
(iii) subjecting said complex to an elevated temperature to dry said semi-solid gel in which said immunodiffusion reaction is visualized, wherein, as the temperature of said complex is elevated, said gel dries evenly to provide a dried gel sheet in which said visualization of said immunodiffusion reaction is preserved.
2. The method of claim 1 in which said gel is an agarose gel and said absorbent web is blotting paper.
3. The method of claim 1 or claim 2 in which said visualized immunodiffusion reaction occurs between an antigen contained in a sample and an antibody contained in said gel.
4. The method of claim 1 or claim 2 in which said visualized immunodiffusion reaction occurs between an antibody contained in a sample and an antigen contained in said gel.
5. A method of claim 1 or claim 2 in which said immunodiffusion reaction occurs between an antigen containing sample solution including a dye and an antibody contained in said semi-solid gel, wherein said visualization of said immunodiffusion reaction is colored by said dye.
6. A method of claim 1 or claim 2 in which said immunodiffusion reaction occurs between an antibody containing sample solution including a dye and an antigen contained in said semi-solid gel, wherein said visualization of said immunodiffusion reaction is colored by said dye.
7. A method for providing a preservable record of an immunodiffusion reaction, said method comprising: (i) providing an immunodiffusion reaction visualized in a hydrated semi-solid gel sheet on a synthetic resin substrate;
(ii) placing a wetted water absorbent web on the surface of said hydrated semi-solid gel sheet in which said immunodiffusion reaction is visualized to provide a complex comprising said semi-solid gel sheet and said water absorbent web ; and
(iii) subjecting said complex to an elevated temperature to dry said semi-solid sheet in which said immunodiffusion reaction is visualized, wherein, as the temperature of said complex is elevated, said dries evenly to provide on said substrate a dried gel sheet in which said visualization record of said immunodiffusion reaction is preserved.
8. The claim 7 method in which said immunodiffusion reaction is a single radial immunodiffusion reaction, a double immunodiffusion reaction, or an electrodiffusion reaction.
9. The claim 7 or claim 8 method in which said semi-solid gel sheet is an agarose gel sheet and said absorbent web is blotting paper.
10. The claim 7 or claim 8 method in which said synthetic resin substrate is a flexible or semi-rigid sheet having a thickness of 1 to 5 mm formed from a polyolefin, a vinyl polymer, or a polycarbonate.
11. The claim 7 or claim 8 method in which said synthetic resin substrate is polyethylene, polypropylene, polyvinylchloride, poly ethylmethacrylate, or polycarbonate.
12. A method for providing a preservable record of a visualization of an immunodiffusion reaction which comprises
(i) providing a support surface; (ii) providing a layer of a hydrated semi-solid gel containing an antibody on said support surface;
(iii) providing at least one hole in said layer of a semi-solid gel on said support surface ; (iv) preparing a buffered liquid sample containing a dye, said sample comprising an antigen which reacts with said antibody in said semi-solid gel to form a precipitate colored by said dye; (v) placing an aliquot of said buffered liquid sample in said at least one hole in said semi-solid gel;
(vi) permitting said antigen and said dye in said sample to diffuse from said at least one hole into said semi-solid gel containing said antibody to produce a precipitate ring colored by said dye which is formed around said at least one hole in said semi-solid gel, said ring indicating reaction of said antigen with said antibody; and (vii) placing a wetted absorbent web on a surface of said semi-solid gel from which said visualized immunodiffusion reaction is apparent to provide complex comprising said semi-solid gel and said absorbent web.
13. A method for providing a preservable record of a visualization of an immunodiffusion reaction which comprises
(i) providing a support surface; (ii) providing a layer of a hydrated semi-solid gel containing an antibody on said support surface;
(iii) providing at least one hole in said layer of a semi-solid gel on said support surface;
(iv) preparing a buffered liquid sample containing a dye, said sample comprising an antibody which reacts with said antigen in said semi-solid gel to form a precipitate colored by said dye;
(v) placing an aliquot of said buffered liquid sample in said at least one hole in said semi-solid gel;
(vi) permitting said antibody and said dye in said sample to diffuse from said at least one hole into said semi-solid gel containing said antigen to produce a precipitate ring colored by said dye which is formed around said at least one hole in said semi-solid gel, said ring indicating reaction of said antibody with said antigen; and
(vii) placing a wetted absorbent web on a surface of said semi-solid gel from which said visualized immunodiffusion reaction is apparent to provide complex comprising said semi-solid gel and said absorbent web.
14. The method of claim 12 in which said semi- solid gel is an agar gel and said absorbent web is blotting paper.
15. The method of claim 12 or claim 14 in which said absorbent web is blotting paper.
16. The method of claim 12 or claim 14 in which said support surface provided in step (ii) is formed from a synthetic resin.
17. The method of claim 12 or claim 14 in which said support surface is a flexible synthetic resin sheet.
18. A preservable record of an immunodiffusion reaction, said preservable record comprising:
(i) a dry agar sheet comprising a substantially undistorted visualization of an immunodiffusion reaction; and
(ii) a polymeric substrate for said dry agar sheet.
19. The preservable record of an immunodiffusion reaction of claim 18, wherein said immunodiffusion reaction is a single radial immunodiffusion reaction, a double immunodiffusion reaction, or an electrodiffusion reaction.
20. The claim 18 or claim 19 preservable record of preservable immunodiffusion reaction in which said polymeric substrate comprises a flexible synthetic resin substrate having a hydrophilic surface coat to which said dry agar sheet adheres.
21. A dry agar sheet bearing a visualized immunodiffusion reaction.
22. A visualization of immunodiffusion reaction in a sheet formed by drying an agarose gel including a visualization of an immunodiffusion reaction.
23. A substantially undistorted visualization of an immunodiffusion reaction in a dry agar sheet.
PCT/US1996/012690 1996-08-02 1996-08-02 A method for preserving and enhancing visualization of immunodiffusion reactions WO1998005964A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US1996/012690 WO1998005964A1 (en) 1996-08-02 1996-08-02 A method for preserving and enhancing visualization of immunodiffusion reactions
AU68425/96A AU6842596A (en) 1996-08-02 1996-08-02 A method for preserving and enhancing visualization of immunodiffusion reactions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/012690 WO1998005964A1 (en) 1996-08-02 1996-08-02 A method for preserving and enhancing visualization of immunodiffusion reactions

Publications (1)

Publication Number Publication Date
WO1998005964A1 true WO1998005964A1 (en) 1998-02-12

Family

ID=22255550

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/012690 WO1998005964A1 (en) 1996-08-02 1996-08-02 A method for preserving and enhancing visualization of immunodiffusion reactions

Country Status (2)

Country Link
AU (1) AU6842596A (en)
WO (1) WO1998005964A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063813A1 (en) * 2017-03-10 2018-09-14 Immuno Diffusion Biotechnologies METHOD AND SYSTEM FOR ASSAYING ANTIGENS BY COLORING RADIAL IMMUNODIFFUSION GELS

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964992A (en) * 1973-12-31 1976-06-22 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Chamber and process for crossed immunoelectro-phoresis
US4198389A (en) * 1976-08-20 1980-04-15 Hoffmann-La Roche Inc. Determination of immunologically active materials and system therefore
US4314897A (en) * 1980-07-01 1982-02-09 Beckman Instruments, Inc. Electrophoretic gel container

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964992A (en) * 1973-12-31 1976-06-22 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Chamber and process for crossed immunoelectro-phoresis
US4198389A (en) * 1976-08-20 1980-04-15 Hoffmann-La Roche Inc. Determination of immunologically active materials and system therefore
US4314897A (en) * 1980-07-01 1982-02-09 Beckman Instruments, Inc. Electrophoretic gel container
US4314897B1 (en) * 1980-07-01 1986-09-30

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ELECTROPHORETIC TECHNIQUES, KOHN, LONDON: ACADEMIC PRESS, 1983, pages 119-148. *
HANDBOOK OF EXPERIMENTAL IMMUNOLOGY, OUCHTERLONY et al., OXFORD: BLACKWELL SCIENTIFIC PUBLICATIONS, 1978, pages 19.1-19.44. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063813A1 (en) * 2017-03-10 2018-09-14 Immuno Diffusion Biotechnologies METHOD AND SYSTEM FOR ASSAYING ANTIGENS BY COLORING RADIAL IMMUNODIFFUSION GELS

Also Published As

Publication number Publication date
AU6842596A (en) 1998-02-25

Similar Documents

Publication Publication Date Title
US3960490A (en) Method and apparatus for detecting immunologic reactions by diffusion in gel
EP0547114B1 (en) Microassay on a card
US3975162A (en) Applying reagent to medium and device therefor
US5126276A (en) Method for the determination and measurements of more than one unknown material in a single surface of a multianalytic assay
EP0335244B1 (en) Solid-phase analytical device and method for using same
EP0138826B1 (en) Detection of human chorionic gonadotropin
US5541069A (en) Assay having improved dose response curve
US5569608A (en) Quantitative detection of analytes on immunochromatographic strips
US3960488A (en) Method and apparatus for quantitative surface inhibition test
JPS5934154A (en) Determination by means of immunoanalytical element
JPH01321359A (en) Liquid conveying apparatus
EP0434800B1 (en) Analytical assay method
EP0270569A1 (en) Cell detection system and method
JPS6069554A (en) Colorimetric immunity testing method on solid surface
JP2003530570A (en) Methods, articles and kits for labeling polymer gels
US4356260A (en) Enzymatic indicator system
JPS63210664A (en) Dry test piece for device using oxygen demand detection system and detecting method of analytic component in fluid to be inspected
WO1998005964A1 (en) A method for preserving and enhancing visualization of immunodiffusion reactions
US5047322A (en) Use of dry analytical elements to determine analytes
JPH04128655A (en) Immunological analytical element and method therefor
CN112526123B (en) Quality control method for degree of polymerization of DNP-BSA (DNP-bovine serum albumin)
WO1993022679A1 (en) Improved wash technique for immunoassay
CA1049401A (en) Method and apparatus for detecting immunologic reactions by diffusion in gel
EP0370417A1 (en) Biological diagnostic assay system
JPS62502060A (en) A new support for in vitro biological testing and applications of this support

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase